Allworth Financial’s Humacyte HUMA Stock Holding History

Allworth Financial’s Portfolio HUMA Stock Details HUMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.02K	Buy	10,281 +4,596	+81%	+$4.26K	﹤0.01%	3859
2026 Q1	$3.45K	Buy	+5,685	New	+$5.91K	﹤0.01%	4151
2025 Q4	–	Sell	-205	Closed	-$357	–	5141
2025 Q3	$357	Sell	205 -152	-43%	-$298	﹤0.01%	4516
2025 Q2	$747	Buy	357 +157	+79%	+$302	﹤0.01%	4033
2025 Q1	$296	Sell	200 -72	-26%	-$270	﹤0.01%	3797
2024 Q4	$1.25K	Buy	272 +72	+36%	+$356	﹤0.01%	3332
2024 Q3	$1.09K	Hold	200	–	–	﹤0.01%	3190
2024 Q2	$1.51K	Hold	200	–	–	﹤0.01%	3027
2024 Q1	$622	Hold	200	–	–	﹤0.01%	3224
2023 Q4	$568	Hold	200	–	–	﹤0.01%	3104
2023 Q3	$586	Hold	200	–	–	﹤0.01%	3003
2023 Q2	$572	Hold	200	–	–	﹤0.01%	2865
2023 Q1	$618	Buy	+200	New	+$569	﹤0.01%	2801

Other funds holding HUMA

Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Allworth Financial's HUMA Position: Q2 2026 in Review

Allworth Financial increased its Humacyte (HUMA) stake by 81% in Q2 2026, buying an estimated $4.26K and bringing the position to 10,281 shares worth $8.02K. The position accounts for ﹤0.01% of the portfolio, ranked #3859.

Allworth Financial first reported a position in HUMA in Q1 2023 and has held it in 13 quarters since. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

Allworth Financial held 10,281 shares of Humacyte worth $8.02K as of Q2 2026.
Allworth Financial bought 4,596 Humacyte shares in Q2 2026, an estimated $4.26K.
Humacyte made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3859 holding.
Allworth Financial first reported a position in Humacyte in Q1 2023 and has held it in 13 quarters since.
161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.